Atricure Inc. buy BTIG Research
Start price
18.02.26
/
50%
€27.40
Target price
18.02.27
€45.59
Performance (%)
-8.76%
Price
22.04.26
€23.00
Summary
This prediction is currently active. With a performance of -8.76%, the BUY prediction by BTIG_Research is trending in the wrong direction. This prediction currently runs until 18.02.27. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -5.738% | -5.738% |
| iShares Core DAX® | 0,41 % | 8,82 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % |
| iShares S&P 500 | 2,44 % | 7,93 % |
Comments by BTIG_Research for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $54.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat